CLX
The Clorox Company
The Clorox Company historical holders
total: 5
Fundsmith The Clorox Company transactions over time
- Total transactions:
- 8
- New positions:
- 2
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 4
- Held since:
- 2023 Q4
- Held for:
- 10 quarters
- Latest activity:
- 2026 Q1
Terry Smith has been an institutional investor in The Clorox Company (CLX) since 2019 Q4. According to 2026 Q1 report, Terry Smith holds 257,217 shares with a market value of roughly $26.66M representing 0.21% of their equity portfolio. The fund/company first acquired CLX in 2019 Q4, initially purchasing about 1.68M shares. Terry Smith later completely sold out the position and reinvested in CLX again in 2023 Q4. Since the initial investment, Fundsmith has made 7 more transactions in this position.
Does Terry Smith still hold CLX?
Yes, Terry Smith continues to hold The Clorox Company (CLX). According to their 2026 Q1 report, they maintain a position of 257,217 shares valued at approximately $26.66M, representing 0.21% of their equity portfolio.
When did Terry Smith first invest in CLX?
Terry Smith first invested in The Clorox Company (CLX) in 2019 Q4 at the reported quarter-end price of $153.54 per share, acquiring 1,682,176 shares in their initial purchase.
What is Terry Smith's average cost basis for CLX?
Based on historical transaction data, Terry Smith's estimated cost basis for The Clorox Company (CLX) is approximately $143.95 per share. This represents their average reported price* across all buy transactions.
Has Terry Smith reinvested in CLX after selling?
Yes, Terry Smith has shown renewed interest in The Clorox Company (CLX). After completely selling their position, they reinitiated an investment in 2023 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $143.95
- Weighted AVG sell price:
- $107.13
CLX transactions history by Fundsmith
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.21%
|
257,217
|
$103.63
|
$26,655,398
|
-58.07% (-356,280)
|
-0.22%
|
|
2024 Q3
|
0.40%
|
613,497
|
$162.91
|
$99,944,796
|
+7.59% (+43,291)
|
+0.03%
|
|
2024 Q2
|
0.32%
|
570,206
|
$136.47
|
$77,816,013
|
-3.05% (-17,935)
|
-0.01%
|
|
2024 Q1
|
0.35%
|
588,141
|
$153.11
|
$90,050,269
|
-2.59% (-15,653)
|
-0.01%
|
|
2023 Q4
|
0.36%
|
603,794
|
$142.59
|
$86,094,986
|
new
|
+0.36%
|
|
2020 Q2
|
0.00%
|
$173.25
|
-100% (-1,592,042)
|
|||
|
2020 Q1
|
1.55%
|
$173.25
|
-5.36% (-90,134)
|
|||
|
2019 Q4
|
1.22%
|
$153.54
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.